Selected research
Market Outlook & Growth Opportunities
Global Dry Eye Products Market Outlook and Growth Opportunities 2026
Market perspective
The global Dry Eye Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Dry Eye Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Dry Eye Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dry Eye Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Dry Eye Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Dry Eye Products market include Sun Pharmaceutical, Johnson & Johnson, Novartis, United Laboratories, Jianfeng Group, AbbVie, URSAPHARM, Thea pharmaceuticals and SIMILASAN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Dry Eye Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Dry Eye Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Dry Eye Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dry Eye Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Dry Eye Products Segment by Company
Sun Pharmaceutical
Johnson & Johnson
Novartis
United Laboratories
Jianfeng Group
AbbVie
URSAPHARM
Thea pharmaceuticals
SIMILASAN
Santen Pharma
Rohto
Prestige Consumer Healthcare
OmniVision Pharma
LION
Kenvue (VISINE)
Bausch & Lomb
Alcon
Akorn
Dry Eye Products Segment by Type
Artificial Tears
Antibiotic Drops
Hormone Drops
Others
Dry Eye Products Segment by Application
Prescription Drugs
OTC Drugs
Dry Eye Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Dry Eye Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Dry Eye Products market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Dry Eye Products significant trends, drivers, influence factors in global and regions.
6. To analyze Dry Eye Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Eye Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dry Eye Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dry Eye Products industry.
Chapter 3: Detailed analysis of Dry Eye Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Dry Eye Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Dry Eye Products in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial Tears
- Antibiotic Drops
- Hormone Drops
- Others
Applications
- Prescription Drugs
- OTC Drugs
Companies covered
- Sun Pharmaceutical
- Johnson & Johnson
- Novartis
- United Laboratories
- Jianfeng Group
- AbbVie
- URSAPHARM
- Thea pharmaceuticals
- SIMILASAN
- Santen Pharma
- Rohto
- Prestige Consumer Healthcare
- OmniVision Pharma
- LION
- Kenvue (VISINE)
- Bausch & Lomb
- Alcon
- Akorn
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Dry Eye Products Sales Value (2021-2032)
- 1.2.2 Global Dry Eye Products Sales Volume (2021-2032)
- 1.2.3 Global Dry Eye Products Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Dry Eye Products Market Dynamics
- 2.1 Dry Eye Products Industry Trends
- 2.2 Dry Eye Products Industry Drivers
- 2.3 Dry Eye Products Industry Opportunities and Challenges
- 2.4 Dry Eye Products Industry Restraints
3 Dry Eye Products Market by Company
- 3.1 Global Dry Eye Products Company Revenue Ranking in 2025
- 3.2 Global Dry Eye Products Revenue by Company (2021-2026)
- 3.3 Global Dry Eye Products Sales Volume by Company (2021-2026)
- 3.4 Global Dry Eye Products Average Price by Company (2021-2026)
- 3.5 Global Dry Eye Products Company Ranking (2024-2026)
- 3.6 Global Dry Eye Products Company Manufacturing Base and Headquarters
- 3.7 Global Dry Eye Products Company Product Type and Application
- 3.8 Global Dry Eye Products Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Dry Eye Products Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Dry Eye Products Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Dry Eye Products Market by Type
- 4.1 Dry Eye Products Type Introduction
- 4.1.1 Artificial Tears
- 4.1.2 Antibiotic Drops
- 4.1.3 Hormone Drops
- 4.1.4 Others
- 4.2 Global Dry Eye Products Sales Volume by Type
- 4.2.1 Global Dry Eye Products Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Dry Eye Products Sales Volume by Type (2021-2032)
- 4.2.3 Global Dry Eye Products Sales Volume Share by Type (2021-2032)
- 4.3 Global Dry Eye Products Sales Value by Type
- 4.3.1 Global Dry Eye Products Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Dry Eye Products Sales Value by Type (2021-2032)
- 4.3.3 Global Dry Eye Products Sales Value Share by Type (2021-2032)
5 Dry Eye Products Market by Application
- 5.1 Dry Eye Products Application Introduction
- 5.1.1 Prescription Drugs
- 5.1.2 OTC Drugs
- 5.2 Global Dry Eye Products Sales Volume by Application
- 5.2.1 Global Dry Eye Products Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Dry Eye Products Sales Volume by Application (2021-2032)
- 5.2.3 Global Dry Eye Products Sales Volume Share by Application (2021-2032)
- 5.3 Global Dry Eye Products Sales Value by Application
- 5.3.1 Global Dry Eye Products Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Dry Eye Products Sales Value by Application (2021-2032)
- 5.3.3 Global Dry Eye Products Sales Value Share by Application (2021-2032)
6 Dry Eye Products Regional Sales and Value Analysis
- 6.1 Global Dry Eye Products Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Dry Eye Products Sales by Region (2021-2032)
- 6.2.1 Global Dry Eye Products Sales by Region: 2021-2026
- 6.2.2 Global Dry Eye Products Sales by Region (2027-2032)
- 6.3 Global Dry Eye Products Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Dry Eye Products Sales Value by Region (2021-2032)
- 6.4.1 Global Dry Eye Products Sales Value by Region: 2021-2026
- 6.4.2 Global Dry Eye Products Sales Value by Region (2027-2032)
- 6.5 Global Dry Eye Products Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Dry Eye Products Sales Value (2021-2032)
- 6.6.2 North America Dry Eye Products Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Dry Eye Products Sales Value (2021-2032)
- 6.7.2 Europe Dry Eye Products Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Dry Eye Products Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Dry Eye Products Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Dry Eye Products Sales Value (2021-2032)
- 6.9.2 South America Dry Eye Products Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Dry Eye Products Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Dry Eye Products Sales Value Share by Country, 2025 VS 2032
7 Dry Eye Products Country-level Sales and Value Analysis
- 7.1 Global Dry Eye Products Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Dry Eye Products Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Dry Eye Products Sales by Country (2021-2032)
- 7.3.1 Global Dry Eye Products Sales by Country (2021-2026)
- 7.3.2 Global Dry Eye Products Sales by Country (2027-2032)
- 7.4 Global Dry Eye Products Sales Value by Country (2021-2032)
- 7.4.1 Global Dry Eye Products Sales Value by Country (2021-2026)
- 7.4.2 Global Dry Eye Products Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.9.2 France Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.16.2 China Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.19.2 India Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Dry Eye Products Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Dry Eye Products Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Dry Eye Products Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Dry Eye Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sun Pharmaceutical
- 8.1.1 Sun Pharmaceutical Company Information
- 8.1.2 Sun Pharmaceutical Business Overview
- 8.1.3 Sun Pharmaceutical Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Sun Pharmaceutical Dry Eye Products Product Portfolio
- 8.1.5 Sun Pharmaceutical Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Dry Eye Products Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Novartis
- 8.3.1 Novartis Company Information
- 8.3.2 Novartis Business Overview
- 8.3.3 Novartis Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Novartis Dry Eye Products Product Portfolio
- 8.3.5 Novartis Recent Developments
- 8.4 United Laboratories
- 8.4.1 United Laboratories Company Information
- 8.4.2 United Laboratories Business Overview
- 8.4.3 United Laboratories Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.4.4 United Laboratories Dry Eye Products Product Portfolio
- 8.4.5 United Laboratories Recent Developments
- 8.5 Jianfeng Group
- 8.5.1 Jianfeng Group Company Information
- 8.5.2 Jianfeng Group Business Overview
- 8.5.3 Jianfeng Group Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Jianfeng Group Dry Eye Products Product Portfolio
- 8.5.5 Jianfeng Group Recent Developments
- 8.6 AbbVie
- 8.6.1 AbbVie Company Information
- 8.6.2 AbbVie Business Overview
- 8.6.3 AbbVie Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.6.4 AbbVie Dry Eye Products Product Portfolio
- 8.6.5 AbbVie Recent Developments
- 8.7 URSAPHARM
- 8.7.1 URSAPHARM Company Information
- 8.7.2 URSAPHARM Business Overview
- 8.7.3 URSAPHARM Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.7.4 URSAPHARM Dry Eye Products Product Portfolio
- 8.7.5 URSAPHARM Recent Developments
- 8.8 Thea pharmaceuticals
- 8.8.1 Thea pharmaceuticals Company Information
- 8.8.2 Thea pharmaceuticals Business Overview
- 8.8.3 Thea pharmaceuticals Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.8.4 Thea pharmaceuticals Dry Eye Products Product Portfolio
- 8.8.5 Thea pharmaceuticals Recent Developments
- 8.9 SIMILASAN
- 8.9.1 SIMILASAN Company Information
- 8.9.2 SIMILASAN Business Overview
- 8.9.3 SIMILASAN Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.9.4 SIMILASAN Dry Eye Products Product Portfolio
- 8.9.5 SIMILASAN Recent Developments
- 8.10 Santen Pharma
- 8.10.1 Santen Pharma Company Information
- 8.10.2 Santen Pharma Business Overview
- 8.10.3 Santen Pharma Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Santen Pharma Dry Eye Products Product Portfolio
- 8.10.5 Santen Pharma Recent Developments
- 8.11 Rohto
- 8.11.1 Rohto Company Information
- 8.11.2 Rohto Business Overview
- 8.11.3 Rohto Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Rohto Dry Eye Products Product Portfolio
- 8.11.5 Rohto Recent Developments
- 8.12 Prestige Consumer Healthcare
- 8.12.1 Prestige Consumer Healthcare Company Information
- 8.12.2 Prestige Consumer Healthcare Business Overview
- 8.12.3 Prestige Consumer Healthcare Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.12.4 Prestige Consumer Healthcare Dry Eye Products Product Portfolio
- 8.12.5 Prestige Consumer Healthcare Recent Developments
- 8.13 OmniVision Pharma
- 8.13.1 OmniVision Pharma Company Information
- 8.13.2 OmniVision Pharma Business Overview
- 8.13.3 OmniVision Pharma Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.13.4 OmniVision Pharma Dry Eye Products Product Portfolio
- 8.13.5 OmniVision Pharma Recent Developments
- 8.14 LION
- 8.14.1 LION Company Information
- 8.14.2 LION Business Overview
- 8.14.3 LION Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.14.4 LION Dry Eye Products Product Portfolio
- 8.14.5 LION Recent Developments
- 8.15 Kenvue (VISINE)
- 8.15.1 Kenvue (VISINE) Company Information
- 8.15.2 Kenvue (VISINE) Business Overview
- 8.15.3 Kenvue (VISINE) Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.15.4 Kenvue (VISINE) Dry Eye Products Product Portfolio
- 8.15.5 Kenvue (VISINE) Recent Developments
- 8.16 Bausch & Lomb
- 8.16.1 Bausch & Lomb Company Information
- 8.16.2 Bausch & Lomb Business Overview
- 8.16.3 Bausch & Lomb Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.16.4 Bausch & Lomb Dry Eye Products Product Portfolio
- 8.16.5 Bausch & Lomb Recent Developments
- 8.17 Alcon
- 8.17.1 Alcon Company Information
- 8.17.2 Alcon Business Overview
- 8.17.3 Alcon Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Alcon Dry Eye Products Product Portfolio
- 8.17.5 Alcon Recent Developments
- 8.18 Akorn
- 8.18.1 Akorn Company Information
- 8.18.2 Akorn Business Overview
- 8.18.3 Akorn Dry Eye Products Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Akorn Dry Eye Products Product Portfolio
- 8.18.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Dry Eye Products Value Chain Analysis
- 9.1.1 Dry Eye Products Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Dry Eye Products Sales Mode & Process
- 9.2 Dry Eye Products Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Dry Eye Products Distributors
- 9.2.3 Dry Eye Products Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst